about
Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cellsComparative genomics of prevaccination and modern Bordetella pertussis strains.Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.Studies on Prn variation in the mouse model and comparison with epidemiological dataPertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age.Small mutations in Bordetella pertussis are associated with selective sweeps.Evidence for a role of the polysaccharide capsule transport proteins in pertussis pathogenesis.Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activityAnalysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.Laboratory Diagnosis of Pertussis.Bordetella pertussis Isolates from Argentinean Whooping Cough Patients Display Enhanced Biofilm Formation Capacity Compared to Tohama I Reference Strain.T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children.Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globallyGlobal population structure and evolution of Bordetella pertussis and their relationship with vaccination.Pertussis: a matter of immune modulation.Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.The virulence factors of Bordetella pertussis: talented modulators of host immune response.Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines.Bordetella pertussis entry into respiratory epithelial cells and intracellular survival.Accelerating control of pertussis in England and Wales.Expression, Purification and Characterization of Three Overlapping Immunodominant Recombinant Fragments from Bordetella pertussis Filamentous Hemagglutinin.Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts
P2860
Q30274818-B8BC7B08-C572-40A9-A1B9-E6075316B69CQ30301113-AA1D52E5-E70D-4C60-AC78-DE6264354B3EQ30656264-14281E5E-2890-49D5-9981-77ED180ECB9CQ33526658-DF01C0E0-1427-494E-86FE-B7CA3DA499C6Q33601872-4A59B872-B572-4210-A8C1-C0E5FB92FD2EQ33744416-6260BF6F-93C8-4DCF-877E-228D5741F8BDQ33769972-0F849024-E60C-4FBA-BF78-99D3846B8625Q33862635-1F6D65A3-3F1E-4D29-97B2-1009614E683BQ34364307-D7F63CAD-1C94-490C-BF84-CA2E2728B5F0Q34431224-8317C928-9FCD-443A-B756-5D5B0FD5CDA2Q34690759-9D5AA9FF-95F6-48B1-9DDC-4A558E875673Q35138820-378C0884-11B1-45F5-A8BC-1561EBEF6C37Q35193398-3F40C7C6-A89C-44C1-9248-710541F610DCQ36073693-B4FDA49F-A49A-493E-8D7F-C26E1660CD94Q36354539-6FFA9451-71D7-4DA0-AFEC-534817EA21E9Q36378601-303A8C23-21FA-47CE-BEA9-160B67CAE0EFQ37452780-BE742447-D476-4331-B31C-482FA959333DQ37714873-99F7B4E0-F06B-4C16-91F6-89AE9A9E4706Q37825920-E709126F-13DC-40DF-9BB1-1FAC861C9FABQ38081288-DC9DDBFF-A7BD-4FED-84F1-08797BCE7001Q38129761-8CCA8990-D949-4DE0-A824-7CAB1B61EB3DQ38956365-55C7C179-DEFD-48AE-A53F-3F0FB8813D7DQ39119096-4A0701EC-827D-4EAA-A2DC-AA0067052C34Q39662144-D8C0EEB4-AB01-4E74-BE92-45274ED5F44DQ43247438-684AB4B9-7439-4E04-8382-5CD00DAA6ED5Q48500160-3462FB31-699C-4358-9768-29E4AAC25D66Q53477986-C8633912-B304-42F7-B0AD-1C26B430AC50Q56380558-EC16C5A0-C514-4B20-9859-087684021696
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving pertussis vaccination.
@en
Improving pertussis vaccination.
@nl
type
label
Improving pertussis vaccination.
@en
Improving pertussis vaccination.
@nl
prefLabel
Improving pertussis vaccination.
@en
Improving pertussis vaccination.
@nl
P356
P1433
P1476
Improving pertussis vaccination.
@en
P2093
Guy A M Berbers
Sabine C de Greeff
P304
P356
10.4161/HV.8112
P50
P577
2009-07-08T00:00:00Z